CT-guided Lung Biopsy Risk Optimization Method — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CT-guided Lung Biopsy Risk Optimization Method — Stella

Recruiting

Back to Pneumothorax trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Switzerland

Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10, Bern

Key details

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment target

~198 participants

Started

September 2025

Primary completion

April 2027

Age range

18 Years – 100 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov